future of health
A new incubator, accelerator and venture builder for biomedicine startups with emphasis on reproductive health
Homu Invest was born as an initiative of:
Dr. Santi Munné Dr. José Horcajadas
Dr. David Cotán Delfí Torns
More than 20 years of senior corporate management and entrepreneurship, and a great vision of future health trends and needs supported this new and challenging project with headquarters in Barcelona and laboratory in Seville.
What do we do?
We’re looking for researchers who have new ideas in:
Reproductive medicine is a branch of medicine concerned with the male and female reproductive systems. It covers their prevention and evaluation, as well as their subsequent treatment and prognosis. Recently it has seen massive advances with the help of technology and research.
Genomics is an interdisciplinary field of biology that focuses on the genome, the complete set of DNA, including all of its genes. The genomics market is gaining ground because of its applications in various fields of study. In this era of medical and life science innovations that are shaped as an inevitable adoption for the sustainability of humanity, genomics research is poised for exponential growth because of the imperative genetic innovations that feed on it.
A medical device is any device intended to be used for medical purposes. They benefit patients by helping health care providers diagnose and treat patients and help them overcome illness or disease, improving their quality of life.
– Drug discovery
– Artificial Intelligence
– Consumer products
What do we offer?
How we help researchers:
From the launch to the implementation of the project
We help find investors and have our own capital for seed phases.
We advise on how to deal with
with the new partners.
How to manage the new company efficiently and professionally.
We have specialists in intellectual property, legal and financial advice.
We offer our own facilities: offices and access to laboratory.
Our mission is to fill in the gaps in the health-care ecosystem so scientists and entrepreneurs could successfully launch their companies globally
– Creating a leading biotech ecosystem
– Transforming scientist into entrepreneurs
– Creating a community of healthcare
– Together we are improving the quality of life
Our main objectives:
– Transfering tech from universities to companies
– Strengthen relations between startups and big companies
– Improve competitiveness
– Support innovation
– Produce successful ventures, create jobs & vitalize society
Venture capital and private equity firms that have invested in our companies
Who we are
Out team members
Dr. Santiago Munne
D. in Human Biology from the University of Pittsburgh and a degree in Biology from the Autonomous University of Barcelona. COO at Overture Life. Founder of: Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life, G1 Sciences. Advisory Board (currently): Overture Life, Phosphorus, MedAnswers, PreVivo, G1 Sciences.
Dr. José Horcajadas
PhD in Molecular Biology and Biochemistry from the Autonomous University of Madrid. He has solid experience in the field of Human Reproduction Genetics, especially in the area of endometrial receptivity, genomics, transcriptomics, implantation and embryo viability.
Dr. David Cotán
Doctor in Biotechnology and Degree in Environmental Sciences from the University Pablo de Olavide (Seville). Entrepreneur, specialized in technical direction and project management in the field of rare diseases, reproduction and enzyme scaling in the Andalusian Centre for Developmental Biology.
CEO Programme by IESE, MBA by la Salle University, Bachelor of Arts Degree by UOC, Business studies degree and Tourism business studies by the University of Barcelona. More than 25 years of executive experience, half of them as Managing Director. Active business angel, writer, business consultant, and independent advisor.
Degree in Business Administration by ESADE and Master in International Business by British Columbia University. Founder and Executive President at Multiplica – one of the best known Spanish-speaking digital consulting firms – and renowned internet expert with a long career as a consultant, teacher, and speaker and author of several books, as well as active business angel.
Daniel (Biologist, Universitat de Barcelona) is the founder and director of Capital Cell and a specialist in early-stage Biotech investment. He has participated in over 50 successful investment rounds totalling well over 35 million euro since 2015 and is one of the leading experts both in equity crowdfunding and in Life Sciences startup investment in Spain.
Sarthak has spent over a decade in healthcare, focusing on several biotech and health tech ventures. His research work has primarily focused on molecular biology and human genetics. He has presented his research at several national and international conferences. Most recently, he developed the first truly non-invasive test for AMH.
Healthcare technology executive, and former 500 startups CTO and CEO, TechCrunch 50 CEO, and multiple-venture backed CTO. Previously architected distributed healthcare systems, designed clinical workflow solutions. Led software team behind IRB-approved clinical trials, developed big data genomics pipeline.
As professors and influencers, we are in touch with the main Universities in Spain and the US
Yale University – CTUS, US
University of Pittsburgh – PAUS, US
EVMS (Eastern Virginia Medical School), US.
UAM (Universidad Autónoma de Madrid), Spain.
UPO (Universidad Pablo de Olavide), Spain.
UJA (Universidad de Jaen), Spain.
UAB (Universitat Autònoma de Barcelona) & UB (Universidad Barcelona), Spain.
UAM (Universidad Autónoma de Murcia), Spain.
Universidad de la Plata, Argentina
Rio Grande do Sur, Brazil
We are members of several international health & management associations:
ESHRE – ASRM – ASEBIR – SEF – PGEDIS
COGEN – PCRS – ACOG – ASHC
YPO (Young President Organization)
Get in touch
Homu Invest headquarters:
Avinguda Diagonal 512, first floor interior, office 1, 08006, Barcelona
Homu Invest central laboratories:
Avda ingeniería n°9 PEASS nave 34,
Copyright © 2020 Homu invest.